| Multiple sclerosis | MS |
| Central nervous system | CNS |
| Myelin oligodendrocyte glycoprotein | MOG |
| Dendritic cells | DC |
| Matrix metalloproteinase | MMP |
| Blood–brain barrier | BBB |
| T helper | Th |
| Integrin | ITG or IT |
| Integrin alpha 4 subunit | ITGA4, ITA4, or CD49d |
| Integrin beta 1 subunit | ITGB1, ITB1, or CD29 |
| Integrin alpha 4 subunit and integrin beta 1 subunit form | α4β1 dimer or very late antigen-4 (VLA-4) |
| Vascular cell adhesion protein | VCAM-1 |
| Simplified molecular-input line-entry system | SMILE |
| Absorption, distribution, metabolism, and excretion parameters | ADME |
| Topological polar surface area | TPSA |
| Molecular weight | MW |
| Split-intein circular ligation of peptides and proteins | SICLOPPS |
| G protein-coupled receptors | GPCRs |
| Post-translational modifications | PTMs |
| Melanocortin receptor family | MCR |
| Root-mean-square deviation | RMSD |
| Accessible surface area | SASA |
| IDSP motif | Ile-Asp-Ser-Pro |
| Drug–target interaction | DTI |
| Extracellular matrix | ECM |
| Tissue inhibitor of matrix metalloproteinase | TIMP |
| Vinculin | VCL |
| Protein tyrosine kinase 2 beta | PTK2B |
| Inside-out signaling pathway regulator of kinases protein | CRK |
| Cytosolic tyrosine kinase that negatively regulates Src family kinases | CSK |
| Adapter protein, which links cell–cell and cell–matrix adhesions to an extended signaling network | BCAR1 |
| Mammalian isoforms of talin | TLN1 |
| Src family protein tyrosine kinases member | SRC |
| Glycoprotein in the ECM fibronectin | FN1 |
| Addressin mucosal addressin cell adhesion molecule-1 | MAdCAM-1 |
| Individual database | ID |
| Protein Data Bank | PDB |
| Molecular dynamics | MD |
| Protein–protein interaction | PPI |
| Food and Drug Administration | FDA |
| Osteopontin | OPN |